.jpg "Hailong Li photo")
assistant research fellow
Department of Pharmacy, West China Second University Hospital, Sichuan University, China (People's Republic)
Li Hailong
Assistant Researcher, Department of Pharmacy/Center for Evidence-Based Pharmacy, West China Second Hospital, Sichuan University, China
Secretary, Evidence-Based Pharmacy Collaborative Group, Division of Clinical Epidemiology and Evidence-Based Medicine, Chinese Medical Association
Chinese Society of Toxicology, Clinical Toxicology Committee, Young Member
Chinese Society of Research Hospitals, Drug Evaluation Committee, Young Member
Ph.D. in Epidemiology and Health Statistics, School of Public Health, Peking University (Supervisor: Prof. Zhan Siyan), with pharmacoepidemiology as his main research interest. He has presided over one National Natural Science Foundation of China (NSFC), participated in one NSFC project, participated in many post-marketing evaluation projects of the National Center for Drug Evaluation (NCDE), and participated in many clinical trial statistical analyses during his postgraduate studies. He has published many papers in English and Chinese on drug utilization, post-marketing safety evaluation, and active monitoring of drug safety signals. He was awarded the Best Oral Presentation Award of ACCP at the Asian Annual Clinical Pharmacy Conference 2021, and the Best Paper Award of ICPE at the International Conference on Pharmacoepidemiology 2019 (one person from around the world each year).